Vimarsana
Biggest News Aggregation in the World

Cipla India News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cipla India. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cipla India Today - Breaking & Trending Today

Kumar: Pharmaceuticals in Uganda alive, kicking - Vimarsana News

Kumar: Pharmaceuticals in Uganda alive, kicking

A 2015 study showed that only 10 percent of drugs on the Uganda pharmaceutical market are manufactured locally. The vast bulk of the medicines are from India and China

Hima, Cipla deals push sector to top of acquisitions list - Vimarsana News

Hima, Cipla deals push sector to top of acquisitions list

The takeovers, which bear a collective value of more than $100 million, have signalled a departure from dull deal-making activity pegged to local manufacturing.

Cipla's takeover by Capital Works stirs Uganda market - Vimarsana News

Cipla's takeover by Capital Works stirs Uganda market

The acquisition took effect November 14, 2023 and the official name will revert to Quality Chemicals Ltd following the change in ownership.

Cipla India sells its stake in Ugandan subsidiary - Vimarsana News

Cipla India sells its stake in Ugandan subsidiary

Cipla Quality Chemicals (QCIL) has sold its majority stake or 51.18 pc of the total company’s ordinary shares to a Mauritius-based investment firm for $25 million (about Shs93.7 b,) after the...

Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India - Vimarsana News

Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India

Date Time Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India – one of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in cr...